DJIA Falls 0.02% This Week to 38714.77 — Data Talk
The Dow Jones Industrial Average is down 7.92 points or 0.02% this week to 38714.77
--Down for three consecutive weeks
--Down 416.76 points or 1.07% over the last three weeks
--Largest three-week point and percentage decline since the week ending Oct. 27, 2023
--Down four of the past five weeks
--Today it is down 190.89 points or 0.49%
--Largest one-day point and percentage decline since Tuesday, March 5, 2024
--Down for two consecutive trading days
--Down 328.55 points or 0.84% over the last two trading days
--Largest two-day point and percentage decline since Wednesday, March 6, 2024
--Off 1.07% from its record close of 39131.53 hit Friday, Feb. 23, 2024
--Up 40.88% from the Election Day close of 27480.03 on Tuesday, Nov. 3, 2020
--Up 24.13% from the Inauguration Day close of 31188.38 on Wednesday, Jan. 20, 2021
--Lowest closing value since Wednesday, March 6, 2024
--Off 1.07% from its 52-week high of 39131.53 hit Friday, Feb. 23, 2024
--Up 21.51% from its 52-week low of 31861.98 hit Friday, March 17, 2023
--Rose 21.51% from 52 weeks ago
--Off 1.07% from its 2024 closing high of 39131.53 hit Friday, Feb. 23, 2024
--Up 3.89% from its 2024 closing low of 37266.67 hit Wednesday, Jan. 17, 2024
--Month-to-date it is down 0.72%
--Year-to-date it is up 1025.23 points or 2.72%
Data based on preliminary market closing values
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 15, 2024 16:29 ET (20:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth